ABSTRACT: The universally conserved signal recognition particle (SRP) and SRP receptor (SR) mediate the cotranslational targeting of proteins to cellular membranes. In contrast, a unique chloroplast SRP in green plants is primarily dedicated to the post-translational targeting of light harvesting chlorophyll a/b binding (LHC) proteins. In both pathways, dimerization and activation between the SRP and SR GTPases mediate the delivery of cargo; whether and how the GTPase cycle in each system adapts to its distinct substrate proteins were unclear. Here, we show that interactions at the active site essential for GTPase activation in the chloroplast SRP and SR play key roles in the assembly of the GTPase complex. In contrast to their cytosolic homologues, GTPase activation in the chloroplast SRP−SR complex contributes marginally to the targeting of LHC proteins. These results demonstrate that complex assembly and GTPase activation are highly coupled in the chloroplast SRP and SR and suggest that the chloroplast GTPases may forego the GTPase activation step as a key regulatory point. These features may reflect adaptations of the chloroplast SRP to the delivery of their unique substrate protein.
C
otranslational protein targeting by the signal recognition particle (SRP) and the SRP receptor (SR) is a universally conserved pathway essential for the proper structure and function of the cell. Cytosolic SRP recognizes ribosomes translating SRP substrates and, via interactions with SR, delivers its cargo the ribosome-nascent chain complexesto the eukaryotic endoplasmic reticulum or the prokaryotic plasma membrane. 1, 2 The functional core of SRP consists of a universally conserved SRP54 subunit, or Ffh in bacteria, and an SRP RNA.
3 SRP54 is comprised of three domains: (i) a methionine-rich M-domain, which provides the binding site for the substrate protein and the SRP RNA; 4 (ii) a GTPase G-domain that shares homology with the Ras-fold; 5 and (iii) an N-terminal N-domain that interacts with the ribosome. 6, 7 Together the N-and G-domains comprise a structural and functional unit called the NG-domain. The SR (FtsY in bacteria) also contains an NG-domain highly homologous to that in SRP54. The GTP-dependent interaction between the NG-domains of SRP and SR guides the delivery of cargo to protein translocation machineries on the target membrane, and subsequent GTP hydrolysis in the complex drives the dissociation of SRP and SR, recycling them for additional rounds of protein targeting. 8 A notable exception to this classic SRP pathway is provided by the chloroplast SRP (cpSRP). 9 The cpSRP pathway still uses the conserved SRP54 and SR GTPases (called cpSRP54 and cpFtsY, respectively). However, cpSRP lacks the otherwise universally conserved SRP RNA and is instead a heterodimeric protein complex comprised of cpSRP54 and cpSRP43, a novel SRP subunit unique to the chloroplast of green plants. 10−13 The most significant difference between the cytosolic and chloroplast SRP pathways lies in the nature of their substrate proteins. The cytosolic SRP must recognize its cargos within a milieu of translating ribosomes in the cytosol, based on signal sequences that differ widely in size, shape, and amino acid composition. In contrast, the cpSRP is dedicated primarily to the post-translational delivery of the light-harvesting chlorophyll a/b binding (LHC) family of proteins. 14, 15 LHC proteins are synthesized in the cytosol and imported into the chloroplast stroma, where they are recognized and captured by the cpSRP. 10 Analogous to the cytosolic SRP pathway, the interaction of cpSRP with cpFtsY brings the LHC proteins to the Albino3 (Alb3) translocase on the thylakoid membrane, where the LHC proteins are integrated and assembled into light harvesting complexes. 16 The similarities and differences between the cytosolic and chloroplast SRP pathways raise intriguing questions: How do the targeting machineries in each pathway meet the unique challenges posed by their substrate proteins, and what are the roles of the SRP and SR GTPases in this adaptation? Extensive work on the cytosolic SRP showed that during the SRP−FtsY interaction a series of discrete conformational changes provide multiple opportunities to exert regulation. 17−21 Assembly of a stable SRP·FtsY complex requires the formation of a transient "early" intermediate, which subsequently rearranges to a stable, "closed" complex. GTPase activation in the complex requires yet another rearrangement, the movement of the highly conserved insertion box domain (IBD) loops, which positions multiple catalytic residues adjacent to the bound GTP molecules and activates GTP hydrolysis. 17 Importantly, each GTPase rearrangement allows the SRP and FtsY to sense and respond to their biological cues. A correct cargo can accelerate the assembly of the SRP·FtsY complex while delaying its GTPase activation. 19 Delayed GTP hydrolysis provides an important time window for the targeting complex to search for the translocation machinery before GTP hydrolysis drives its irreversible disassembly. Once at the target membrane, the movement of the IBD loops, which mediates GTPase activation, is crucial for driving the initiation of protein translocation. 22 Finally, the timing of GTP hydrolysis provides an important fidelity checkpoint: incorrect cargos, which fail to delay GTPase activation, could be more promptly rejected through premature GTP hydrolysis. 19 Thus, the uncoupling of complex assembly and GTPase activation steps in the bacterial SRP and FtsY is crucial for ensuring the efficiency and fidelity of cotranslational protein targeting.
On the other hand, the cpSRP handles substrate proteins of a completely different nature. The LHC family of proteins comprises 30−50% of the protein content in the thylakoid membrane and are likely the most abundant membrane proteins on earth. The sheer abundance and rapid turnover of these proteins demand a highly robust and efficient pathway for their targeting and integration. Compared to its cytosolic homologue, specific substrate selection is much easier to achieve in the cpSRP, as members of the LHC protein family are highly homologous and share a conserved sequence motif, L18, that is specifically recognized by the cpSRP. Consequently, many features have evolved in the cpSRP pathway that may represent adaptations to its unique substrate proteins. For example, cpSRP uses cpSRP43 to efficiently capture the LHC proteins 23 as well as to help localize the targeting complex to Alb3 on the thylakoid membrane. 24 Here we address this issue from a different perspective: what are the similarities and differences in the GTPase cycles of the chloroplast versus cytosolic SRP and SR? Are there distinct features of the cpSRP54 and cpFtsY GTPases that may reflect their adaptation to the cpSRP pathway? Using a combination of fluorescence and mutational analyses, we dissected the molecular steps during the interaction of cpSRP54 and cpFtsY and probed the role of the GTPase cycle in the targeting of LHCP. The results showed that, despite many similarities with their bacterial homologues, cpSRP54 and cpFtsY undergo a much more streamlined GTPase cycle in which the complex formation and GTPase activation processes are highly coupled. These differences may have evolved to maximize the efficiency of targeting for the highly abundant LHC proteins.
■ MATERIALS AND METHODS

Mutagenesis, Protein Expression, and Purification.
The bacterial expression plasmid for cpSRP54 was constructed by inserting the coding sequence of mature cpSRP54 from Arabidopsis thaliana between the NdeI and HindIII restriction sites in pET41(a) (Novagen). cpSRP54 was overexpressed in Escherichia coli Rosetta BL21 cells (Invitrogen) at 37°C using 0.5 mM IPTG (EMD Biosciences). cpSRP54 was purified by cation exchange chromatography in buffer A (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5% glycerol), first using SP-Sepharose FF beads (GE Healthcare), followed by a MonoS HP column (GE Healthcare), both using a linear gradient of 150−600 mM NaCl.
The construct expressing mature cpFtsY fused to thioredoxin is a generous gift from R. Henry. 25 Thioredoxin-fused cpFtsY was overexpressed in Escherichia coli BL21-DE3* cells (Invitrogen) at 37°C using 0.5 mM IPTG (EMD Biosciences). cpFtsY was first purified over Talon resin (Clonetech) in buffer B (50 mM KHEPES, pH 7.5, 150 mM NaCl, 1 mM PMSF) following manufacturer's instructions. Following thrombin digestion to remove the thioredoxin tag, cpFtsY was further purified by anion exchange chromatography over a MonoQ column (GE Healthcare) in buffer C (50 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA, 2 mM DTT) using a linear gradient of 50−300 mM NaCl, as previously described. 26 cpSRP54 and cpFtsY mutants were constructed using the QuikChange protocol (Stratagene) and were expressed and purified using the same procedures as those for the wild-type cpSRP54, with the following exceptions. Cys-less and single cysteine mutants of cpFtsY were expressed in Escherichia coli BL21-DE3* cells (Invitrogen). Inclusion bodies containing mutant cpFtsY were solubilized using 8 M urea. Solubilized cpFtsY was refolded into the native structure by dialyzing in refolding buffer (100 mM Tris-HCl pH 8.0, 400 mM L-arginine, 5 mM reduced glutathione, 0.5 mM oxidized glutathione, complete EDTA free protease inhibitor cocktail tablet). The refolded proteins were dialyzed in buffer A and purified by affinity chromatography using Ni-NTA (Qiagen) followed by anion exchange chromatography using MonoQ as described above for wild-type cpFtsY.
Fluorescence Labeling. For FRET experiments, single cysteine mutants were labeled with maleimide derivatives of coumarin N-(7-dimethylamino-4-methylcoumarin-3-yl)-maleimide (DACM) and BODIPY-fluorescein-N-(2-aminoethyl)maleimide (BODIPY-FL) (Invitrogen). Proteins were dialyzed in labeling buffer (50 mM KHEPES, pH 7.5), 300 mM NaCl, 2 mM EDTA, and 10% glycerol) and treated with 2 mM TCEP at RT to reduce disulfide bonds. The labeling reaction was carried out with a 30-fold excess of dye over protein for 2 h at 4°C and stopped by addition of 2 mM DTT. Acrylodan labeling was done similarly except that the labeling reaction was carried out for >12 h at 4°C. The excess dye was removed by gel filtration using Sephadex G25 resin (SigmaAldrich). The absorbance of DACM, BODIPY-FL, and acrylodan (ε 363 = 27 000 M −1 cm −1 , ε 504 = 79 000 M −1 cm −1 , and ε 391 = 20 000 M −1 cm −1 , respectively) was used to determine the concentration of labeled protein. The labeling efficiency was typically over 80% for all the probes, and the background labeling estimated from cys-less or cys-lite constructs was less than 10%.
Fluorescence Measurement. All measurements were carried out at 25°C in assay buffer (50 mM KHEPES pH 7.5, 150 mM KOAc, 2 mM Mg(OAc) 2 , 0.01% Nikkol, 10% glycerol) on a Fluorolog 3-22 spectrofluorometer (Jobin Yvon). For formation of the GTP-bound cpSRP54·cpFtsY complex, 2 mM GTP (Sigma-Aldrich) was used to ensure that both proteins were predominantly GTP-bound. The amount of GDP generated during the course of the experiment was minimal, as estimated from the GTPase rate constants. For complex formation with 5′-guanylylimidodiphosphate (GMPPNP), 200 μM GMPPNP (Sigma-Aldrich) was used. For equilibrium or kinetic measurements using FRET, an excitation wavelength of 380 nm was used, and the donor fluorescence emission was monitored at 450 nm. The FRET efficiency was calculated as described. 18 For measurements using acrylodan-labeled cpSRP54, an excitation wavelength of 370 nm and an emission wavelength of 495 nm were used. 19 Equilibrium titrations were carried out using a constant concentration of labeled protein and varying concentrations of the binding partner. The data were fit to eqs 1 or 2 (1) (2) where F obs is the observed fluorescence at a particular protein concentration, F 1 is the fluorescence with saturating protein, and K d is the equilibrium dissociation constant of the complex.
The association rate constant (k on ) for the cpSRP54·cpFtsY complex was measured using the stop-flow apparatus as described in ref 18 . For FRET, 0.5 μM DACM-labeled cpFtsY was mixed with 1−50 μM BODIPY-FL-labeled cpSRP54 in the presence of 2 mM GTP. For measurements based on acrylodan fluorescence, 0.5 μM acrylodan-labeled cpSRP54 was mixed with 1−50 μM wild-type cpFtsY. The observed rate constants (k obs ) for each reaction was plotted against cpSRP54 or cpFtsY concentration, respectively, and fitted to a linear (eq 3) or hyperbolic function (eq 4) (3) (4) in which k obs is observed rate of association at a particular protein concentration, k on (slope) is the association rate constant and k off ;app (y-intercept) is the apparent dissociation rate constant, and k 1 and K d are defined in Figure 2E .
The dissociation rate constant (k off ) was determined by a pulsechase experiment. 2 μM wild-type cpFtsY was incubated with 0.5 μM acrylodan-labeled cpSRP54(234C, A142W) for 10 min to form the GTP-bound cpSRP54·cpFtsY complex and mixed with 200 mM EDTA or a 20-fold excess of unlabeled cpSRP54 to drive disassociation of the complex. The time course for decrease in acrylodan fluorescence was fit to a single-exponential function to obtain the dissociation rate constant. Both the complex association and dissociation kinetics were measured on a Kintek stopped-flow apparatus.
GTPase Assays. All GTPase assays were performed at 25°C in assay buffer as described previously. 26 GTP hydrolysis reactions were followed and analyzed as described in ref 27 . The reciprocally stimulated GTPase reaction between cpFtsY and cpSRP was measured in multiple-turnover experiments ( [GTP] > [E]) with a small fixed amount of cpSRP54 (100 nM), varying concentrations of wild-type or mutant cpFtsY, and 100 μM GTP. The cpFtsY concentration dependence of the observed rate (k obs ) was fit to eq 5 (5) in which k cat is the maximal rate constant with saturating cpFtsY and K m is the concentration of cpFtsY required to reach half saturation. Analogous setups were used when cpSRP54 mutants were tested, with the concentration of cpSRP54 being varied instead of cpFtsY.
The affinity of mutant cpFtsY for cpSRP54 was determined using an inhibition assay that measures the ability of mutant cpFtsY to compete with wild-type cpFtsY and inhibits its interaction with cpSRP54, as described in Shan et al. 17 The data were fit to eq 6 (6) in which K i is the inhibition constant, k 0 is the rate constant of GTP hydrolysis in the absence of the inhibitor, and k 1 is the rate constant of GTP hydrolysis from the cpSRP54·cpFtsY(mt) complex. At subsaturating concentrations of the wild-type cpFtsY (<K m ), the value of K i equals K d , the dissociation constant of the cpSRP54·cpFtsY(mt) complex. Analogous setups and analyses were used when cpSRP54 mutants were tested.
Gel Filtration. Complex formation was carried out in column buffer [50 mM KHEPES, pH 7.5, 200 mM NaCl, 2 mM Mg(OAc) 2 , 2 mM DTT]. 10 μM of cpSRP54 was mixed with 10 μM wild-type or mutant cpFtsY in the presence of 450 μM GMPPNP and incubated on ice for 10 min before loading onto Superdex 200 (GE Healthcare). Reference runs of the individual proteins confirmed the identities of the peaks.
LHCP Integration Assay. The thylakoids were collected from chloroplasts of 9−12 day old pea seedlings (Laxton Progressive 9) hypotonically lysed in lysis buffer (10 mM KHEPES, pH 8.0, 10 mM MgCl 2 ) for 10 min as described by Yuan et al. 28 The stromal extract was removed, and the thylakoid pellet was resuspended in lysis buffer and washed twice in import buffer (50 mM KHEPES, pH 8.0, 330 mM sorbitol) containing 1 M KOAc to remove residual cpFtsY associated with the membrane. Thylakoids were resuspended in import buffer to a concentration of 1 mg chlorophyll/mL (1×). Each 150 μL light-harvesting chlorophyll a/b binding protein (LHCP) targeting/integration reaction contained 10 μL of in vitro translated 35 S-methionine-labeled LHCP, 50 μL of 1× salt-washed thylakoid, 50 mM GTP, 50 mM ATP, 0.5 μM cpSRP54, and varying concentrations of cpFtsY. Analogous setups were used when cpSRP54 mutants were tested. The reactions were incubated at 25°C for 10 min before being quenched on ice. The reaction mixtures were thermolysintreated for 40 min and centrifuged to remove any nonintegrated LHCP in the supernatant. The resulting pellets were resuspended in 2× SDS and analyzed by SDS-PAGE. The two lower bands that represent the protease-protected fragments of the integrated LHCP (25 and 18.5 kDa) were quantified using a Molecular Dynamics Storm 840 and the ImageQuant software (GE Healthcare).
■ RESULTS
Fluorescence Assays To Monitor the cpSRP54−cpFtsY
Interaction. To directly visualize the interaction between cpSRP54 and cpFtsY in real time, we developed fluorescencebased assays, which have been used in the bacterial SRP and other systems to elucidate key features of protein interaction mechanisms. To this end, we constructed cys-lite and cys-less versions of cpSRP54 and cpFtsY, respectively. cpSRP54 has a Biochemistry Article dx.doi.org/10.1021/bi200742a | Biochemistry 2011, 50, 7208−7217 solvent exposed cysteine 198 which can be mutated to serine to obtain cys-lite cpSRP54 without disrupting its interaction with cpFtsY ( Figure S1A of Supporting Information); the remaining two cysteines in cpSRP54 are likely buried inside the folded protein based on homology modeling with Ffh and did not react significantly with fluorescent dyes in control experiments ( Figure S1B of Supporting Information). cpFtsY contains five native cysteines, all of which were replaced with serines. Cysless cpFtsY was purified from inclusion bodies and refolded into the native structure. Refolded cys-less cpFtsY interacted with and stimulated cpSRP54's GTPase activity with efficiencies within 2-fold of that of wild-type cpFtsY ( Figure S1C of Supporting Information).
As the crystal structure of cpSRP54 or its complex with cpFtsY is not available, we constructed a homology model of the cpSRP54·cpFtsY complex based on superposition of the crystal structure of apo-cpFtsY onto that of T. aquaticus FtsY in complex with Ffh ( Figure 1A ). On the basis of this model, single cysteines were introduced at solvent exposed positions and labeled with fluorescent dyes using thio-specific chemistry.
In FRET experiments, a cysteine was engineered at residue 321 of cys-less cpFtsY and labeled with DACM as the donor fluorophore, and a cysteine was introduced at residue 234 of cys-lite cpSRP54 and labeled with BODIPY-FL as the acceptor dye ( Figure 1A ). Both probes are located at the N−G domain interface of the respective GTPases and are ∼30 Å apart as estimated from the homology model. Significant FRET was observed upon assembly of the cpSRP54·cpFtsY complex in the presence of GTP ( Figure 1B) . At saturating protein concentrations and when complications from GTP hydrolysis were minimized (see below), the FRET efficiency in the cpSRP54·cpFtsY complex was ∼0.60 ( Figure 2F ). In addition, the cysteine at residue 234 of cys-lite cpSRP54 was labeled with an environmentally sensitive dye, acrylodan. Formation of the cpSRP54·cpFtsY complex with GTP induced a blue shift and a ∼30% increase in the fluorescence intensity of this dye ( Figure 1C) , providing an additional measurement of the cpSRP54−cpFtsY interaction. Fluorescently labeled cpSRP54 and cpFtsY interacted with and activated each other's GTPase activity with rate constants within 2-fold of the wild-type proteins ( Figure S1D ,E of Supporting Information). Further, both the FRET and fluorescence change of cpSRP54(234C)-acrylodan upon complex formation could be competed away by EDTA or unlabeled protein ( Figure S2A ,B of Supporting Information). Thus, these fluorescence assays faithfully report on the kinetics and stability of the cpSRP54−cpFtsY interaction. Two-Step Complex Assembly. Using the fluorescence assays, we characterized the kinetics and stability of the interaction between cpSRP54 and cpFtsY. These analyses, however, were complicated by the hydrolysis of GTP, which occurs quickly in the cpSRP54·cpFtsY complex and drives rapid disassembly of the GTPase complex. In the bacterial SRP and FtsY GTPases, this problem can be overcome by using the nonhydrolyzable GTP analogue GMPPNP, which provides a good mimic for GTP to support efficient assembly of a stable SRP·FtsY complex. 18 However as shown below ( Figure 2F ), GMPPNP does not provide an adequate mimic of GTP to support stable complex assembly between cpSRP54 and cpFtsY. To overcome this problem, we used the mutant GTPases, cpSRP54(A142W) or cpFtsY(A168W). The corresponding mutations in bacterial SRP and FtsY, Ffh(A144W) and FtsY(A335W), respectively, specifically disrupted GTPase activation in the Ffh·FtsY complex without affecting rapid and stable complex assembly. 17 Similarly, both mutants in cpSRP54 and cpFtsY allowed a stable cpSRP54·cpFtsY complex to be efficiently assembled ( Figures 3B and 4B ), but specifically blocked GTP hydrolysis in the complex, and thus provided a reasonable estimate for the kinetic and thermodynamic stabilities of the wild-type cpSRP54·cpFtsY complex.
We determined the kinetics of complex assembly in the presence of GTP by following either the gain of FRET (Figure 2A) or the increase in fluorescence of acrylodan-labeled cpSRP54 ( Figure 2B) . Surprisingly, the complex assembly rate constant (k on ) measured using FRET was over 3-fold faster than that determined using cpSRP54(234C)-acrylodan ( Figure 2C ). This difference was not caused by a larger deleterious effect of acrylodan labeling at cpSRP54(234C) on complex assembly, as cpSRP54(234C)-acrylodan exhibited comparable activity in the stimulated GTPase reaction than the cpSRP54 and cpFtsY labeled with the FRET dyes (compare Figures S1D and S1E of the Supporting Information, •). Instead, we reasoned that the difference in the observed complex assembly rates arises from the fact that the acrylodan probe reports on a local conformational change surrounding residue 234 that accompanies complex assembly, whereas FRET directly reports on approximation of distance between cpSRP54 and cpFtsY as soon as a complex is formed. This raised the possibility that assembly of the stable cpSRP54−cpFtsY complex occurs in two steps, with the initial formation of an intermediate detected by FRET followed by conformational rearrangement to form a more stable, final complex detected specifically by cpSRP54-(234C)-acrylodan.
To provide additional evidence for this model, we analyzed the concentration dependence of the observed complex assembly rates using cpSRP54(234C)-acrylodan. If formation of a stable complex occurred in a single bimolecular association, then the observed complex assembly rate constants should increase linearly with increasing protein concentration. In contrast, if additional steps were required for stable complex assembly, deviations from linearity would be expected. Indeed, the observed complex assembly rate constant exhibited a hyperbolic dependence on cpFtsY concentration and plateaued at 6 s −1 with saturating cpFtsY ( Figure 2D ). Control experiments showed that this plateau was unlikely to be caused by protein aggregation or inactivation at high concentrations Complex formation with GTP was carried out using mutant cpFtsY(A168W) to minimize GTP hydrolysis. The data were fit to eq 2, which gave K d values of 0.35 μM with GTP and 7 μM with GMPPNP. (G) Dissociation kinetics of the cpSRP54(234C, A142W)·cpFtsY complex, measured as described in the Materials and Methods. Single-exponential fit of the data gave an apparent dissociation rate constant of 0.038 s −1 . After subtracting the GTP hydrolysis rate from this complex (0.008 s −1 ), the corrected dissociation rate constant was 0.030 s −1 . Figure 2E ), such that complex formation is rate-limited by the bimolecular cpSRP54−cpFtsY association at low protein concentrations but becomes rate-limited by a unimolecular rearrangement from this intermediate at saturating protein concentrations. Together, these results strongly suggest that assembly of the cpSRP54·cpFtsY complex requires at least two steps. We further determined the kinetic and thermodynamic stabilities of the cpSRP54·cpFtsY complex. The affinity of the cpSRP54·cpFtsY complex was measured by equilibrium titrations using mutant cpSRP54(A142W) or cpFtsY(A168W), as rapid GTP hydrolysis from the wild-type complex will artificially raise the observed equilibrium dissociation constant (K d ) ( Figure 2F vs Figure S3A of Supporting Information, •). These analyses yielded a K d value of 300−500 nM using both the FRET assay and acrylodan-labeled cpSRP54 ( Figure 2F and Figure S3B ,C of Supporting Information). In addition, pulse-chase experiments gave a dissociation rate constant of 0.03 s −1 for the cpSRP54(A142W)·cpFtsY complex ( Figure 2G ). In conjunction with the association rate constant measured above ( Figure 2C ), this yielded a K d value of 200 nM for this complex, consistent with the value determined from equilibrium titrations.
IBD Loops Play Essential Roles in Both Complex
Assembly and GTPase Activation. To probe the molecular determinants essential for the interaction between cpSRP54 and cpFtsY, we generated a collection of site-directed mutant GTPases that map to the putative interaction surface of cpSRP54 and cpFtsY based on structural homology, with an emphasis on the universally conserved IBD loops ( Figure 1A , magenta, and Tables S1 and S2 of Supporting Information). Control experiments showed that the basal GTP binding and hydrolysis activity (Tables S3 and S4 of Supporting Information, respectively) of the individual cpFtsY and cpSRP54 mutants were comparable to that of the wild-type proteins, ensuring that defects did not arise from disruption of the global structure of the mutant proteins. We then screened the mutants by monitoring the reciprocally stimulated GTPase reaction between cpSRP54 and cpFtsY ( Figures 3A,B and  4A ,B). As demonstrated above, the complex assembly rate constants measured directly using the fluorescence assays agreed well with the value of k cat /K m (∼3 × 10 5 M −1 s −1 ) in the stimulated GTPase reaction; further, dissociation of the GTP• cpSRP54·cpFtsY
•GTP complex (0.030 s −1 ) is at least 20-fold slower than GTP hydrolysis from this complex (∼0.7 s −1 ). Both observations indicate that in the stimulated GTPase reaction the value of k cat /K m is rate-limited by, and hence reports on, the rate of assembly of a stable cpSRP54−cpFtsY complex, whereas the maximal rate constant k cat reports on either GTP hydrolysis from the complex or a rate-limiting rearrangement that activates the chemical step.
The vast majority of mutants exhibited defects in this reaction (Table 1 and Tables S1, S2 of Supporting Information). Among them, perturbations of the IBD loops produced the most deleterious effect on the reciprocally stimulated GTPase reaction between cpSRP54 and cpFtsY (Table 1) , consistent with their high evolutionary conservation. Inspection of the concentration dependence of the stimulated GTPase reactions further suggested that the majority of these mutants have defects in both the complex assembly and GTP hydrolysis steps. For example, the cpFtsY(A169W) and the corresponding cpSRP54(A143W) mutations not only reduced the GTPase rate from the complex by over 50-fold (Figures 3A and 4A and  Table 1 , k cat ), but a significantly higher concentration of mutant proteins were required to reach saturation ( Figures 3A and 4A , insets and Table 1 , K m ). Only two mutations, cpFtsY(A168W) and cpSRP54(A142W), were exceptions: both mutants reduced the maximal rate of GTP hydrolysis by 15−50-fold (Figures 3B  and 4B and Table 1 , k cat ), but saturation in GTPase rate could be reached at low protein concentrations, suggesting that efficient complex assembly could occur in these mutants ( Figures 3B and 4B , insets, and Table 1 , K m ).
To further dissect the contribution of each residue to complex assembly and/or GTPase activation, we used a wellestablished inhibition assay ( Figures 3C and 4C) . 17 For example, if a mutant cpFtsY could bind cpSRP54 but failed to efficiently hydrolyze GTP, then it would compete with wildtype cpFtsY in binding and inhibit its stimulated GTPase reaction with cpSRP54. Under subsaturating concentrations of the wild-type cpSRP54 and cpFtsY, the inhibition constant K i obtained from this assay represents the dissociation constant between the mutant and its partner GTPase. In agreement with their kinetic parameters from the stimulated GTPase reactions, cpFtsY(A168W) and cpSRP54(A142W) exhibited strong competitive binding to its partner GTPase, with inhibition constants below 0.2 μM (Figures 3C and 4C , open circles, and Table 1 , K i ). In contrast, all the other deleterious mutations in the IBD loop severely impaired complex formation (Table 1) . For example, cpFtsY(A169W) and cpSRP54(A143W) could not act as competitive inhibitors in the inhibition assay and exhibited K i values over 50 μM ( Figures 3C and 4C, •) .
To independently corroborate the results from the inhibition assay, we used gel filtration and fluorescence analyses to independently evaluate the mutational effects on the stability and/or conformational changes of the complex. In gel filtration analyses, which qualitatively assess the ability of the mutant proteins to form a kinetically stable complex, 29, 30 cpSRP54-(A142W) and cpFtsY(A168W) assembled complexes with efficiencies within 2-fold of the wild-type proteins ( Figures 3D  and 4E, red vs black) . On the other hand, all the other deleterious mutations in the IBD loops (residues D163, R166, A169 of cpFtsY and D137, R140, A143 of cpSRP54) showed no or little detectable complex formation ( Figures 3D and 4E) . Similarly, fluorescence assays showed that mutant cpSRP54-(A142W) exhibited the same complex assembly rate constant as wild-type cpSPR54 ( Figure 4D ), and both cpSRP54-(A142W) and cpFtsY(A168W) assembled stable complexes with their binding partners ( Figure S3B ,C of Supporting Information). In contrast, complex formation could not be detected for mutants cpSRP54(D137A) and cpSRP54(A169W) using the fluorescence assay (data not shown). Together, these results strongly suggest that the IBD loops, which provide key catalytic motifs for GTPase activation, are also intimately involved in the assembly of the cpSRP54−cpFtsY complex.
Two additional lines of evidence support this notion and showed that in the cpSRP54·cpFtsY complex interactions at the catalytic active site are tightly coupled to assembly of the GTPase complex. First, several mutations in the IBD loop of cpSRP54 caused extensive blue shift and increase in fluorescence intensity of the acrylodan labeled at cpSRP54-(234C) compared to that of wild-type cpSRP54 ( Figure 4F ). This indicates that perturbation of the IBD loop effects a change in the local environment at the NG-domain interface of cpSRP54, a region critical for efficient complex assembly (Table S1 of Supporting Information and ref 30) . Second, replacement of the β,γ-bridging oxygen of GTP strongly reduced both the rate (data not shown) and the stability of the complex ( Figure 2F) , and GMPPNP could not induce the change in the fluorescence of acrylodan-labeled cpSRP54-(234C) upon complex formation (data not shown). Thus, interactions at sites critical for the chemical reaction are also integrally involved in the complex assembly process.
Defects in Complex Formation and GTPase Activation Block LHCP Targeting. To assess the contribution of the individual steps in cpSRP54 and cpFtsY's GTPase cycle to the protein targeting reaction, we tested the effects of the mutant cpFtsY and cpSRP54 GTPases on the targeting and translocation of LHCP. The overall efficiency of LHCP targeting and integration was analyzed based on protease protection of LHCP upon its proper integration into salt-washed thylakoid membranes (see Materials and Methods). In vitro translocation reached completion after 10 min and the reaction saturated at cpFtsY concentrations above 150 nM ( Figures S5A and S5B of Supporting Information, respectively). On the basis of these observations, a concentration of 500 nM and a time point of 10 min were used to test the effect of mutant proteins on the efficiency of the targeting reaction.
In general, a significant defect in LHCP integration was observed only with a >10-fold reduction in the individual steps of cpSRP54 and cpFtsY's GTPase cycle (complex formation or GTPase activation). This is analogous to observations in the cotranslational protein targeting reaction carried out by bacterial SRP and FtsY 31 and suggests that the targeting of LHCP by cpSRP and cpFtsY is not the major rate-limiting step in the translocation/integration assay. Nevertheless, this assay Figure 2F and Figure S3 of the Supporting Information.
c Apparent K d values were obtained from equilibrium titrations using acrylodan-labeled cpSRP54 in Figure S3 of the Supporting Information. revealed moderate to strong defects in LHCP integration for most of the mutant GTPases ( Figures 5A,B and S5C of Supporting Information). The two mutants that specifically block GTPase activation, cpSRP54(A142W) and cpFtsY(A168W), reduced translocation efficiency ∼2-fold ( Figure 5A,B) , suggesting that activated GTP hydrolysis in the cpSRP54·cpFtsY complex is not crucial but does modulate the efficiency of the targeting reaction. In comparison, mutant GTPases that also impair complex assembly, such as cpFtsY(A169W) and cpSRP54(A143W), showed stronger defects in LHCP targeting and translocation ( Figure 5A,B) . The reduction in translocation efficiency of the various GTPase mutants correlated with their values of k cat /K m in the GTPase assay, an indicator for the efficiency of complex assembly ( Figure  5C,D) . Collectively, these results demonstrate that efficient assembly of the cpSRP54−cpFtsY complex is crucial for the targeting and integration of LHCP, whereas GTPase activation and/or GTP hydrolysis plays a modulatory role to help enhance the efficiency of targeting.
■ DISCUSSION
The interaction between the SRP and SR GTPases delivers cargo proteins to a target membrane and hence plays a crucial role in the proper localization of membrane proteins. During the interaction of the bacterial SRP and SR, formation of a stable complex is a two-step process that requires initial formation of a transient "early" intermediate, followed by a slow rearrangement of this intermediate to a stable complex ( Figure 6 , black line, steps 1 and 2). 18 Here, real-time fluorescence analyses strongly suggest that a two-step assembly process also occurs during the interaction between cpSRP54 and cpFtsY. First, the complex assembly rate constant measured by acrylodan, which detects a local rearrangement at the NG-domain interface accompanying complex formation, is significantly slower than that reported by the FRET probes, which are less sensitive to the conformational state of the complex. Further, the observed complex assembly rate constant exhibits a hyperbolic, instead of linear, dependence on protein concentration. Both observations are indicative of the presence of an intermediate during complex assembly ( Figures 2E and 6 (Figure 6 , red vs black lines, step 2). These observations suggest that the transient intermediate assembled by the chloroplast GTPases is more productive and possibly requires less extensive rearrangements to attain the final complex than their bacterial homologues. This is consistent with our previous observation that cpFtsY is preorganized into a conformation more conducive to stable complex assembly than the bacterial FtsY. 26, 32 An important feature of the bacterial SRP system is that movement of the IBD loops, which activates GTP hydrolysis, can be conceptually and experimentally uncoupled from the rearrangements in the rest of the protein that mediate stable complex assembly. 17, 22 Numerous mutations in the IBD loops result in specific inhibition of GTPase activation, without significantly disrupting formation of the complex. 17 Given these observations, it was surprising to find that the vast majority of mutations in the IBD loops of cpSRP54 and cpFtsY severely compromised assembly of the GTPase complex. This raises the possibility that in the cpSRP54·cpFtsY complex these two steps are more tightly coupled, as the catalytic active sites are also intimately involved in the assembly of the complex. Supporting this notion is the observation that conservative perturbations at the site of chemical transformation, such as replacement of the β, γ-bridging oxygen of GTP with −NH−, severely disrupted complex stability and assembly rate, in contrast to the bacterial SRP with which GMPPNP specifically inhibits GTP hydrolysis. 31 Further, mutations of the IBD loops induced large changes in the fluorescence of an acrylodan dye over 30 Å away at the NG-domain interface, suggesting that the GTPase active sites are intimately linked to sites crucial for complex assembly. Taken together, these observations suggest that during the interaction between cpSRP54 and cpFtsY the complex formation and GTPase activation steps are highly coupled, in contrast to the cytosolic SRP·FtsY complex in which these processes occur in two distinct molecular steps ( Figure 6, step 3, black vs red  lines) .
What gives rise to this difference? To address this question, one might begin by reflecting on the role of the multiple conformational steps during the assembly and activation of the cytosolic SRP·FtsY complex. Uncoupling complex formation and GTPase activation allows each of these steps to provide an independent fidelity checkpoint, thus providing the SRP multiple opportunities to reject the incorrect cargos. 19 This is crucial for the bacterial SRP to achieve a high fidelity of substrate selection, as it has to recognize highly divergent signal sequences and to distinguish between the correct and incorrect cargos based on subtle variations. 20 We speculate that the absence of a similar challenge in attaining specific substrate selection may underlie the different behavior of the chloroplast GTPases. In contrast to the cytosolic SRP, the cpSRP is primarily dedicated to a highly conserved LHC family of proteins, and the cpSRP43 subunit can provide highly specific recognition of these substrates. 14, 15, 23 Although cpSRP54 also participates in the cotranslational targeting of several membrane proteins (such as D1 protein), 33 the number and diversity of these substrates are much more limited than those handled by the cytosolic SRP. It could therefore be envisioned that the chloroplast SRP system can afford to forego the GTPase activation step as an additional regulatory point.
Consistent with this notion, GTPase activation plays a less essential role in protein targeting by the cpSRP than the cytosolic SRP pathway. In the cytosolic SRP pathway, mutant GTPases that specifically block the activation of GTP hydrolysis severely inhibit protein targeting at late stages. 31 Thus, the molecular rearrangements that lead to GTPase activation, notably the movement of the IBD loops, play an essential role in the unloading of cargo from the SRP and the initiation of protein translocation. In contrast, mutations that specifically inhibit GTPase activation in the cpSRP54·cpFtsY complex resulted in only a 2-fold reduction in the targeting of LHCP. Although in previous reports, the observation that GMPPNP inhibited LHCP targeting has implicated a crucial role of GTP hydrolysis for LHCP targeting and integration, 24, 25 our findings here suggest that these defects could instead arise from the failure of GMPPNP to support efficient and stable cpSRP54−cpFtsY complex assembly. Indeed, mutant GTPases that impair complex assembly between cpSRP54 and cpFtsY led to much larger deleterious effects on LHCP targeting, and the defects in their targeting efficiency correlated with their defects in complex assembly. Thus, GTPase activation or GTP hydrolysis plays a modulatory role in enhancing the targeting efficiency of LHCP but is not as crucial as is the case with the cytosolic SRP. The ability of cpSRP43 to directly interact with the Alb3 translocase and thus regulate substrate binding and release 24, 34 might allow the cpSRP pathway to bypass the use of GTPase activation as a critical mechanism to drive the unloading of cargo from the cpSRP; this possibility remains to be tested.
Collectively, these results suggest a more streamlined cpSRP54−cpFtsY interaction cycle compared to their bacterial homologues (Figure 6 ), which might be a consequence of their adaptation to targeting a different set of substrate proteins. This pair of GTPases is primed to efficiently form a complex with one another and to quickly turn over the complex (through rapid GTP hydrolysis), bypassing conformational steps that serve as important fidelity checkpoints in the bacterial SRP pathway. These features could allow the cpSRP pathway to cater to the LHC family of proteins, whose sequence conservation allows specific substrate selection to be more easily achieved, but whose high abundance demands a highly efficient targeting pathway with rapid turnover. In this light, one might further speculate that the complex series of dynamic conformational changes observed for the bacterial SRP·FtsY GTPase complex could be fine-tuned to allow efficient targeting only in response to the correct signal sequences while minimizing the targeting of empty ribosomes and incorrect cargo proteins. The divergent properties of the bacterial and chloroplast SRP and FtsY GTPases might reflect different mechanisms to achieve the balance between efficiency and selectivity as the two pathways adapt to distinct challenges posed by their substrate proteins.
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